Michael Haude News Today

First-in-Human Study Also Showed the Return of Vasomotion in Patients Treated with the DREAMS 3G Scaffold

Germany: The one-year small BIOMAG-1 study results have shown that serial coronary imaging of patients with a resorbable magnesium scaffold (Biotroniks Dreams 3G) for coronary artery disease...

Serial OCT data presented this week at EAS 2023 suggest the vessel shows signs of stabilization, says Hector Garcia-Garcia.

Early results promising with DynamX bioadaptor, though traditional BRS hasn't been abandoned

R-One+ is a robotic solution that allows the interventional cardiologist to perform coronary angioplasties by controlling the devices using an integrated control command unit located in the cathlab or in the control room 

Six-month results from the BIOMAG-I clinical study including intravascular imaging data were presented at CRT 2023

Late lumen loss with a new bioabsorbable drug-eluting stent is on par with nonabsorbable devices in early data.

The multi-center first-in-men study evaluates the safety and performance of the next generation of BIOTRONIK’s Resorbable Magnesium Scaffold (RMS) 

Share: Cardiovascular Systems, Inc. (CSI ®) (NASDAQ:CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that it has received CE Mark for its Diamondback 360 ®Coronary Orbital Atherectomy System (OAS) and ViperWire Advance ® Coronary Guide Wire with Flex Tip (ViperWire Advance with Flex Tip). The Diamondback 360 ®Coronary OAS is the market-leading coronary atherect...